4-Bromo-3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole

Catalog No. :
ACIVDR084
CAS No. :
51108-52-2
Molecular Formula :
C8H13BrN2
Molecular Weight :
217.11

IUPAC Name:4-bromo-1-isopropyl-3,5-dimethyl-1H-pyrazole

4-Bromo-3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00Login to see priceInquiryInquiry
250mg95%$715.00Login to see priceInquiryInquiry
1g95%$730.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole
IUPAC Name4-bromo-1-isopropyl-3,5-dimethyl-1H-pyrazole
MDL No.MFCD16687035
Molecular FormulaC8H13BrN2
Molecular Weight217.11
SMILESCC(N1N=C(C)C(Br)=C1C)C
InChI KeyCXKZTTNVIBHWAQ-UHFFFAOYSA-N
Synonym4-bromo-1-isopropyl-3,5-dimethyl-1H-pyrazole;1H-Pyrazole, 4-bromo-3,5-dimethyl-1-(1-methylethyl)-;4-bromo-3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole;4-bromo-1-isopropyl-3,5-dimethylpyrazole
CAS No.51108-52-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIVDR084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDXZ618 route compound structure diagram
    ACIDXZ6183398-16-1 In Stock
  4. Then
  5. ACIVDR084 route product structure diagram
    ACIVDR08451108-52-2
Inquiry

2. ACIVDR084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDXZ618 route compound structure diagram
    ACIDXZ6183398-16-1 In Stock
  4. Then
  5. ACIVDR084 route product structure diagram
    ACIVDR08451108-52-2
Inquiry

Comments (0)